Multicenter phase I clinical trial of daily and weekly RAD001 (everolimus) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer with prior resistance to trastuzumab.

Author(s):  
A Fasolo ◽  
L Gianni ◽  
A Rorive ◽  
J Bergh ◽  
V Dieras ◽  
...  
2015 ◽  
Vol 4 (7) ◽  
pp. 1051-1059 ◽  
Author(s):  
Pavani Chalasani ◽  
Marilyn Marron ◽  
Denise Roe ◽  
Kathryn Clarke ◽  
Maria Iannone ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document